PortfoliosLab logoPortfoliosLab logo
BNGO vs. BYND
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

BNGO vs. BYND - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bionano Genomics, Inc. (BNGO) and Beyond Meat, Inc. (BYND). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BNGO vs. BYND - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
BNGO
Bionano Genomics, Inc.
-22.22%-91.16%-84.74%-87.05%-51.17%-2.92%148.39%-68.61%
BYND
Beyond Meat, Inc.
-24.34%-78.19%-57.75%-27.70%-81.11%-47.87%65.34%14.98%

Fundamentals

EPS

BNGO:

-$9.02

BYND:

$1.03

PS Ratio

BNGO:

0.12

BYND:

0.47

Total Revenue (TTM)

BNGO:

$28.51M

BYND:

$275.50M

Gross Profit (TTM)

BNGO:

$13.51M

BYND:

$7.65M

EBITDA (TTM)

BNGO:

-$19.47M

BYND:

-$290.85M

Returns By Period

In the year-to-date period, BNGO achieves a -22.22% return, which is significantly higher than BYND's -24.34% return.


BNGO

1D
1.71%
1M
4.39%
YTD
-22.22%
6M
-31.61%
1Y
-61.61%
3Y*
-87.87%
5Y*
-80.91%
10Y*

BYND

1D
-11.57%
1M
-24.80%
YTD
-24.34%
6M
-73.14%
1Y
-79.79%
3Y*
-66.31%
5Y*
-65.74%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BNGO vs. BYND — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNGO
BNGO Risk / Return Rank: 1515
Overall Rank
BNGO Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
BNGO Sortino Ratio Rank: 1515
Sortino Ratio Rank
BNGO Omega Ratio Rank: 1313
Omega Ratio Rank
BNGO Calmar Ratio Rank: 1515
Calmar Ratio Rank
BNGO Martin Ratio Rank: 2121
Martin Ratio Rank

BYND
BYND Risk / Return Rank: 2323
Overall Rank
BYND Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
BYND Sortino Ratio Rank: 3636
Sortino Ratio Rank
BYND Omega Ratio Rank: 3535
Omega Ratio Rank
BYND Calmar Ratio Rank: 77
Calmar Ratio Rank
BYND Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNGO vs. BYND - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bionano Genomics, Inc. (BNGO) and Beyond Meat, Inc. (BYND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BNGOBYNDDifference

Sharpe ratio

Return per unit of total volatility

-0.64

-0.35

-0.29

Sortino ratio

Return per unit of downside risk

-0.74

0.28

-1.02

Omega ratio

Gain probability vs. loss probability

0.89

1.04

-0.15

Calmar ratio

Return relative to maximum drawdown

-0.74

-0.91

+0.17

Martin ratio

Return relative to average drawdown

-1.06

-1.42

+0.35

BNGO vs. BYND - Sharpe Ratio Comparison

The current BNGO Sharpe Ratio is -0.64, which is lower than the BYND Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of BNGO and BYND, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BNGOBYNDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.64

-0.35

-0.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.88

-0.53

-0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

-0.43

+0.08

Correlation

The correlation between BNGO and BYND is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

BNGO vs. BYND - Dividend Comparison

Neither BNGO nor BYND has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BNGO vs. BYND - Drawdown Comparison

The maximum BNGO drawdown since its inception was -99.99%, roughly equal to the maximum BYND drawdown of -99.78%. Use the drawdown chart below to compare losses from any high point for BNGO and BYND.


Loading graphics...

Drawdown Indicators


BNGOBYNDDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-99.78%

-0.21%

Max Drawdown (1Y)

Largest decline over 1 year

-77.85%

-87.85%

+10.00%

Max Drawdown (5Y)

Largest decline over 5 years

-99.98%

-99.67%

-0.31%

Current Drawdown

Current decline from peak

-99.99%

-99.74%

-0.25%

Average Drawdown

Average peak-to-trough decline

-83.33%

-74.98%

-8.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

53.86%

56.13%

-2.27%

Volatility

BNGO vs. BYND - Volatility Comparison

Bionano Genomics, Inc. (BNGO) has a higher volatility of 33.96% compared to Beyond Meat, Inc. (BYND) at 26.90%. This indicates that BNGO's price experiences larger fluctuations and is considered to be riskier than BYND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BNGOBYNDDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.96%

26.90%

+7.06%

Volatility (6M)

Calculated over the trailing 6-month period

49.48%

170.86%

-121.38%

Volatility (1Y)

Calculated over the trailing 1-year period

97.14%

231.18%

-134.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.44%

124.51%

-32.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

193.73%

115.54%

+78.19%

Financials

BNGO vs. BYND - Financials Comparison

This section allows you to compare key financial metrics between Bionano Genomics, Inc. and Beyond Meat, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
7.95M
61.59M
(BNGO) Total Revenue
(BYND) Total Revenue
Values in USD except per share items